The United States on Friday approved the first blood test for Alzheimer's, a move that could help patients begin treatment earlier with newly approved drugs that slow the progression of the ...

The United States on 16 May 2025 approved the first blood test for Alzheimer's, a move that could help patients begin treatment earlier with newly approved drugs that slow the progression of the ...

Alzheimer’s disease is currently diagnosed with expensive medical imaging or invasive methods that require a spinal tap. Patients now have an alternative. The FDA has cleared a new Fujirebio ...

A recent meta-analysis reveals a concerning link between long-term use of anticholinergic drugs and an elevated risk of dementia, particularly Alzheimer's disease. The study indicates that ...

Dr. Charles DeCarli, co-director of the UC Davis Alzheimer’s Research Center, got the news in a call from a colleague on March 24. “Your study was terminated.” DeCarli had been conducting a ...

For the millions of Americans affected by Alzheimer's. The road to battling the disease has been bumpy but an experimental medication is offering new hope. It's not *** cure. It is not going to be ...